They suppress appetite, making it easier to eat less without feeling deprived, and they improve blood sugar regulation, which is one reason they were originally developed for diabetes treatment
2020, doi: 10.1016/S2213-8587(19)30382-1
If your current intake is low, increase it gradually rather than all at once, as a sudden increase can cause bloating and digestive discomfort
Basina and Blyumin emphasized that patients shouldnt panic or stop a medication abruptly particularly if its used to manage diabetes
Tesamorelin has a more established evidence base, primarily in the context of HIV-associated lipodystrophy, where pivotal randomised controlled trials (including Falutz et al., NEJM, 2010) demonstrated statistically significant reductions in visceral adipose tissue
Opportunities for general internal medicine to promote equity in obesity care